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Abstract
Objective—We evaluated the effectiveness and cost of a fungal meningitis outbreak response in
the New River Valley of Virginia during 2012–2013 from the perspective of the local public
health department and clinical facilities. The fungal meningitis outbreak affected 23 states in the
United States with 751 cases and 64 deaths in 20 states; there were 56 cases and 5 deaths in
Virginia.
Methods—We conducted a partial economic evaluation of the fungal meningitis outbreak
response in New River Valley. We collected costs associated with the local health department and
clinical facilities in the outbreak response and estimated the epidemiological effectiveness by
using disability-adjusted life years (DALYs) averted.
Results—We estimated the epidemiological effectiveness of this outbreak response to be 153
DALYs averted among the patients, and the costs incurred by the local health department and
clinical facilities to be $30,413 and $39,580, respectively.
Conclusions—We estimated the incremental cost-effectiveness ratio of $198 per DALY averted
and $258 per DALY averted from the local health department and clinical perspectives,
respectively, thereby assisting in impact evaluation of the outbreak response by the local health
department and clinical facilities.
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Fungal meningitis occurs in individuals infected by the predominant pathogen Exserohilum
rostratum, which spreads in the spinal cord through the bloodstream and leads to swelling of
the protective membrane of the spinal cord or brain. Fungal meningitis is not contagious and
is not transmitted directly between people. The pathogen can be found in soil, water, food,
air, and vegetation. People exposed to this fungal pathogen generally experience no adverse
effects. However, immunocompromised people are at higher risk for developing fungal
infection and symptomatic effects. Symptoms include meningitis, encephalitis, and stroke.
During the multistate fungal meningitis outbreak in the United States during 2012–2013,
exposed patients with mild symptoms of fever, headache, back pain, or other relevant
symptoms were also tested.1
Multistate Fungal Meningitis Outbreak
In September 2012, the Tennessee Department of Health confirmed cases of Aspergillus
fumigatus meningitis following epidural steroid injection. After Tennessee, 19 other states
reported cases caused by the predominant pathogen Exserohilum rostratum.2 The cause of
the multistate fungal meningitis outbreak was traced to fungal-contaminated lots of
preservative-free methylprednisolone acetate that were used in the epidural steroid injections
and were produced in a compounding pharmacy, the New England Compounding Center in
Framingham, Massachusetts.3 More than 13,000 patients had received the fungal-
contaminated epidural steroid injections in 23 states and were at risk of developing fungal
meningitis. The outbreak was the largest outbreak associated with steroid injections.4 There
were 751 cases and 64 deaths in 20 states as of October 23, 2013; additional cases are not
anticipated.5
Fungal Meningitis Case Definition
The Centers for Disease Control and Prevention (CDC) defined a probable fungal meningitis
case as a patient who had received the fungal-contaminated epidural injections after May 21,
2012, with symptoms of meningitis, stroke, spinal infections, osteomyelitis, or arthritis of
peripheral joints. Probable cases with evidence of the fungal pathogen in culture,
histopathology, or molecular assay were also defined as confirmed cases.
Fungal Meningitis Outbreak in Virginia
Virginia reported the fourth highest number of cases with 56 cases and 5 deaths. Two
clinical facilities in Virginia had administered these fungal-contaminated injections, with
one facility located in New River Valley and the other facility located in neighboring
Roanoke. New River Health District personnel conducted disease surveillance, case
reporting, and referral of probable cases to clinical facilities for diagnostics, treatment, or
hospitalization.
Clinical Response
The CDC released treatment guidelines, and voriconazole therapy was the recommended
treatment.5 Confirmed cases in Virginia were prescribed similar treatment, and voriconazole
therapy improved prognosis among the treated patients.6
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Multi-sectoral Public Health Response
The multistate fungal meningitis outbreak was controlled through a multi-sectoral public
health response, as illustrated in Figure 1. The outbreak response required effective
coordination between patients and immediate caregivers; treatment administered through
hospitals, clinics, and pharmacies; and a systematic effort between the public health
agencies at the local, state, and federal levels. The outbreak was widely publicized after
October 4, 2013, and the multisectoral public health response by CDC and its partners
averted 3150 methylprednisolone acetate injections, 153 cases of meningitis or stroke, and
124 deaths, in comparison to the 60-day case-fatality rates and clinical characteristics of
fungal meningitis patients diagnosed before October 4, 2013.7
New River Health District
New River Health District is one of 35 local health districts of the Virginia Department of
Health in Virginia and includes the counties of Floyd, Giles, Montogomery, Pulaski, and the
city of Radford.8 It is among 11 health districts in Virginia with residents who were injected
with fungal-contaminated epidural steroids. In this study, “local health department” refers to
New River Health District.
Study Objective
The objective of this study was to evaluate the effectiveness and cost of the fungal
meningitis outbreak response in the New River Valley of Virginia from the perspectives of
the local public health department and clinical facilities.
Related Studies
In a related study, we conducted an economic evaluation of the fungal meningitis outbreak
response in New River Valley from the local public health department perspective.9 In this
article, we extend the prior study to include the cost estimates from the clinical response to
evaluate the effectiveness and cost of the fungal meningitis outbreak response in New River
Valley from both the clinical and local public health department perspectives. We also
conducted a systematic review of the clinical response, outbreak investigation, and
epidemiology of the fungal meningitis outbreak in the United States.10 The multi-sectoral
public health response to the fungal meningitis epidemic from the hospitals, clinics,
pharmacies, and the public health system at the local, state, and federal levels led to an
efficient epidemiological investigation to trace the outbreak source and rapid
implementation of multiple response plans. The systematic review reaffirmed the effective
execution of a multi-sectoral public health response and efficient delivery of the core
functions of public health assessment, policy development, and service assurances to
improve population health.
Public Health Significance
The multistate fungal meningitis outbreak affected Virginia with 56 cases and 5 deaths.
Impact evaluation of the outbreak response in New River Valley can assist the local health
department and clinical facilities in optimization and prioritization of limited resources.
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METHODS
Surveillance and Outbreak Investigation by New River Health District
The timeline of the fungal meningitis outbreak response by the New River Health District
and clinical facilities in New River Valley was from October 2012 to March 2013. A total of
91 patients were exposed to the fungal-contaminated epidural steroids and were followed up
for further assistance. The local health department implemented the surveillance system for
follow-up with the affected patients on the basis of guidelines from the CDC. Figure 2
shows the surveillance and outbreak response process implemented by the New River
Health District. When the multistate outbreak was confirmed by the CDC, personnel from
New River Health District visited the clinical facilities in New River Valley and Roanoke
where the exposed patients received the fungal-contaminated epidural steroid injections and
collected their information. The local health department personnel were in continuous
contact with the state health department and the CDC to get the updated information
regarding the probable symptoms and updated case definition. The health district
epidemiologist and volunteers then contacted patients and screened them for specific clinical
symptoms. Patients with symptoms specific to fungal meningitis were referred to their local
clinical facility for further lab tests. The epidemiologist contacted the patients’ physicians or
local emergency department to provide information about probable patients who may get
admitted with confirmed symptoms. The epidemiologist also provided up-to-date
information and recommendations for managing symptomatic patients in the clinical
facilities. If the results of the lab test met the case definition, the patient was referred to the
local hospital for further medical care. If the patient did not have any further symptoms, the
local health department personnel continued to follow up with the patient for 6 months after
the last dose of the contaminated injection.
Cost and Effectiveness of the Fungal Meningitis Outbreak Response
Cost and effectiveness of the fungal meningitis outbreak response by the New River Health
District and clinical facilities were compared to the do-nothing alternative (scenario of no
intervention). We assessed effectiveness by the combined epidemiological impact of
morbidity and mortality by using the metric of disability-adjusted life years (DALYs)
averted.11
Do-Nothing Alternative
Fungal meningitis is a rare disease, and the last recorded outbreak prior to the 2012–2013
outbreak was in 2002 with 5 cases.12 Health departments currently do not include fungal
meningitis in their list of diseases or health conditions as part of the reportable disease or
sentinel surveillance process and case-reporting activities. Therefore, we evaluated the
fungal meningitis outbreak response in comparison to the do-nothing alternative in this
economic evaluation.
Costs
We estimated the direct cost incurred by the New River Health District for the fungal
meningitis outbreak response on the basis of the total hours spent by the local health
department personnel involved in the outbreak response and corresponding hourly wages.
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The outbreak response team in the local health department includes the epidemiologist,
health district director, planner, environmental health manager, clerical staff, administrative
staff, nurse epidemiologist, and volunteers. Data were provided by the New River Health
District. Direct cost incurred by the clinical facilities was estimated on the basis of the total
cost of clinical care for the patients exposed to fungal-contaminated epidural steroid
injections.
Epidemiological Effectiveness
Effectiveness measures the epidemiological impact of the fungal meningitis outbreak
response, using the metric of DALYs.11 DALYs measures the burden of (disease) fungal
meningitis as a combined metric of the epidemiological impacts of morbidity and mortality.
Morbidity impact was measured by years of life lost due to disability (YLD), and mortality
impact was measured by years of life lost due to premature mortality (YLL). Disability
weight was used to quantify the disease severity on a scale of 0 (equivalent of perfect health)
to 1 (equivalent of death).13 DALYs are the primary health metric used to measure the
disease burden in the Global Burden of Diseases, Injuries and Risk Factors Study,14–17
which includes data and analytics on premature death and disability from more than 300
diseases and injuries in 188 countries, by age and sex, from 1990 to 2015, allowing
comparisons over time, across age groups, and among populations.
The equations for YLD, YLL, and DALY are below:
(Eq 1)
(Eq 2)
(Eq 3)
Cost-Effectiveness
Cost-effectiveness was measured by using the incremental cost-effectiveness ratio (ICER).
The ICER is computed as the ratio of the difference in costs and the difference in
effectiveness (burden of disease) of the fungal meningitis outbreak response by the local
health department and clinical facilities compared to the do-nothing alternative. The
equations for ICER are below:
(Eq 4)
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(Eq 5)
Ethics Approval
Ethics approval for this study was received from the institutional review boards of Virginia
Tech and the Virginia Department of Health.
RESULTS
Time Horizon
We conducted the economic evaluation of the fungal meningitis outbreak response in New
River Valley by using the time horizon of October 2012 to March 2013.
Discount Rate
No discount rate was used because the time horizon of the study was less than a year.
Decision Tree
Figure 3 illustrates the decision tree to compare the fungal meningitis outbreak response of
the local health department and clinical/hospital facilities with the do-nothing alternative. In
the outbreak response branch, positively diagnosed patients may receive treatment while
negatively diagnosed patients do not receive treatment with corresponding costs and health
benefits. Positively diagnosed patients may recover with treatment or die from fungal
meningitis. The recovery rate of positively diagnosed patients with treatment was 90.32%.5
On the do-nothing branch, the positively diagnosed patients have a case fatality rate of
100%. There are no available or recorded estimates of case fatality rate among untreated
fungal meningitis patients. The 100% case fatality rate among untreated fungal meningitis
patients is based on the input of TMK (infectious disease physician who led the clinical
response to the fungal meningitis outbreak in New River Valley) that fungal meningitis, if
left untreated, leads to a fatal outcome.
Cost: Local Health Department
Table 1 includes the distribution of costs among the local health department personnel of the
New River Health District who were involved in the fungal meningitis outbreak response.
The hours spent by the personnel in the outbreak response and the corresponding hourly
wages were provided by the New River Health District. We estimated that $30,413.20 was
spent by the local health department in response to the fungal meningitis outbreak in New
River Valley.
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Cost: Clinical
Table 2 includes the distribution of costs of clinical care for patients who received fungal-
contaminated epidural steroid injections in New River Valley. Among the 91 exposed
patients, 12 lumbar punctures and 14 cerebrospinal fluid cultures were done, and 9 patients
were admitted to clinical facilities in Montgomery, Salem, and Pulaski counties or Roanoke
city. The average length of stay in these clinical facilities was 2.5 days with a range of
between 0 and 11 days for hospitalized patients. These data were obtained from the hospital
records and patients’ files. We estimated the cost associated with lumbar puncture of
outpatients from the study by Tung et al,18 the cost of cerebrospinal fluid cultures of
outpatients from the study by Barenfanger et al,19 and the cost of hospitalization of
inpatients from the hospital records data. We estimated that $39,579.84 was spent by the
clinical facilities in response to the fungal meningitis outbreak in New River Valley.
Cost: Local Health Department and Clinical
The local health department incurred a cost of $30,413.20 and the clinical facilities incurred
a cost of $39,579.84 for a combined cost of $69,993.04 in the fungal meningitis out-break
response in New River Valley from October 2012 to March 2013.
Disability Weight
Disability weight specific to fungal meningitis is not available, because it is a novel and rare
disease. Bacterial meningitis and fungal meningitis have similar symptoms.20 Thereby, we
used the disability weight of 0.615 for bacterial meningitis13,21 as the disability weight for
fungal meningitis.
Years of Life Lost Due to Disability
None of the 91 patients in the New River Health District met the case definition of fungal
meningitis as defined by CDC. Using the average attack rate of 8.6% for fungal meningitis
in Virginia among the patients who had received the contaminated epidural steroid
injections, it was estimated that there would be 7.785 potential cases in New River Valley,
as illustrated in Table 3. The average duration of treatment is 4 months for recovered
patients, whereas the average duration of treatment among the fatal patients was near null.
Using Eq 1, 90.32% of patients who survived the fungal meningitis due to intervention were
getting treatment for 4 months on average. Patients who recovered from successful treatment
lost 1.427 DALYs to account for the morbidity impact caused by fungal meningitis during
the treatment duration. Thereby, we estimated the YLD to be −1.427 DALYs averted due to
the fungal meningitis outbreak response compared to the do-nothing alternative.
Years of Life Lost Due to Premature Mortality
The case fatality rate of fungal meningitis patients was 9.678% with treatment, whereas it is
100% without treatment. The average life expectancy in Virginia is 79 years,23 whereas the
average age of patients in Virginia who were injected with fungal-contaminated epidural
steroids was 57 years. Using Eq 2, we estimated the YLL to be 154.69 DALYs averted due
to the fungal meningitis outbreak response compared to the do-nothing alternative.
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Epidemiological Effectiveness (DALY = YLD + YLL)
Using Eq 3, we estimated the total DALYs to be 153.26 DALYs averted due to the fungal
meningitis outbreak response compared to the do-nothing alternative. The computations of
YLDs, YLLs, and DALYs are illustrated in Table 4.
Cost-Effectiveness
Using Eq 4, the ICERs from the local health department perspective, clinical facilities
perspective, and total (including both local health department and clinical facilities
perspectives) were computed to be $198.43, $258.24, and $456.67, respectively, per DALY
averted due to the fungal meningitis outbreak response compared to the do-nothing
alternative.
Uncertainty and Sensitivity Analysis
We conducted sensitivity analysis for the duration of treatment, attack rate, and disability
weight.
Duration of Treatment—We estimated that treatment duration had an average of 4
months with a range of (1.5 months, 18 months). The corresponding impact on the ICER
was ($197.29, $205.21) per DALY averted from the local health department perspective,
($256.76, $267.06) per DALY averted from the clinical perspective, and ($454.05, $472.26)
per DALY averted from the local health department and clinical perspectives.
Attack Rate—We estimated the attack rate to be 8.6% (range: 1%, 17%) depending on the
epidural injection lot. We tested 6 potential scenarios if all the epidural injections
administered to the patients in New River Valley had come from the 6 different lot numbers,
as shown in Table 3. The corresponding impact on the ICER was ($1697.58, $99.86) per
DALY averted from the local health department perspective, ($2209.23, $129.96) per
DALY averted from the clinical perspective, and ($3906.81, $229.81) per DALY averted
from the local health department and clinical perspectives.
Disability Weight—We estimated the disability weight for fungal meningitis to be 0.615
with a 95% confidence interval of (0.613, 0.616). The corresponding impact on the ICER
was ($198.43, $198.44) per DALY averted from the local health department perspective,
($258.23, $258.24) per DALY averted from the clinical perspective, and ($456.66, $456.68)
per DALY averted from the local health department and clinical perspectives.
DISCUSSION
Local health departments conducted disease surveillance, case reporting, and referral of
probable cases to clinical facilities for diagnostics, treatment, and/or hospitalization during
the 2012–2013 multistate fungal meningitis outbreak in the United States. We estimated the
total direct costs incurred by New River Health District and clinical facilities for the fungal
meningitis outbreak response to be $69,993.04. We estimated a morbidity impact of −1.427
DALYs for YLD averted and a mortality impact of 154.69 DALYs for YLL averted, for a
combined morbidity and mortality impact (burden of fungal meningitis) of 153.26 DALYs
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averted for epidemiological effectiveness of the fungal meningitis outbreak response
compared to the do-nothing alternative. We estimated the ICER of the fungal meningitis
outbreak response in New River Valley to be $198.43, $258.24, and $456.67 per DALY
averted from the local health department, clinical, and combined local health department and
clinical perspectives, respectively, compared to the do-nothing alternative.
Partial Economic Evaluation
Although the fungal meningitis outbreak response required a coordinated effort by the CDC,
the Food and Drug Administration (FDA), and state and local health departments and
included the clinical response of diagnosis and treatment, this analysis was only from the
local health department and clinical perspectives. While epidemiological effectiveness
among patients in New River Valley was a combined result of the coordinated effort of the
health departments (local, state, and federal) and the clinical facilities (laboratories and
hospitals), the cost calculations included only the costs incurred by the local health
department and hospitals or clinics. Owing to this asymmetry in the boundaries of
calculation of effectiveness and costs, this study was a partial economic evaluation of the
fungal meningitis outbreak response in New River Valley.
Limitations
New River Health District and the Virginia Department of Health currently do not use a
threshold to judge whether an intervention or public health program is cost-effective, and
correspondingly we do not infer whether the fungal meningitis outbreak response was cost-
effective. The cost calculations did not include indirect costs incurred by New River Health
District or clinical facilities. Scientific studies and clinical knowledge on fungal meningitis
are lacking, because it is a relatively rare disease. Thereby, the disability weight of fungal
meningitis was estimated by using the disability weight of bacterial meningitis, because both
diseases have common symptoms. There were variations in the cost calculations among the
different clinical facilities in New River Valley. While the fungal meningitis outbreak
response required a coordinated effort by the CDC, the FDA, and state and local health
departments,24,25 the focus of this economic evaluation was only from the local health
department and clinical perspectives.
CONCLUSIONS
Economic evaluation of the fungal meningitis outbreak response in New River Valley assists
the local health department and clinical facilities to analyze the costs and epidemiological
effectiveness of the outbreak response compared to the do-nothing alternative. We estimated
the epidemiological effectiveness to be 153.26 DALYs averted, and the ICER to be $456.67
per DALY averted from the local health department and clinical perspective. The DALY
metric provides a uniform metric to estimate and compare the burden of different diseases,
and the ICER ($/DALY averted) provides a uniform metric to evaluate and compare the
impact of different disease control and prevention programs, thereby assisting in the
prioritization of public health programs.
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FIGURE 1. Multi-sectoral Response to the Fungal Meningitis Outbreak
The multistate fungal meningitis outbreak was controlled through effective coordination
between patients and immediate caregivers; treatment administered through hospitals,
clinics and pharmacies; and a systematic effort between the public health agencies at the
local, state, and federal levels. Abbreviations: CDC, Centers for Disease Control and
Prevention; FDA, Food and Drug Administration.
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FIGURE 2. Fungal Meningitis Outbreak Response in New River Valley, Virginia
New River Valley patients who were administered fungal-contaminated epidural injections
in the 2 clinical facilities of New River Valley and Roanoke were contacted by personnel of
New River Health District. Exposed patients were followed up weekly for 3 months and
monthly for another 3 months. Symptomatic patients were referred to lab tests, and
positively diagnosed patients were referred to hospitals for treatment.
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FIGURE 3. Decision Tree Comparing the Fungal Meningitis Outbreak Investigation in New
River Health District With the Do-Nothing Alternative
Positively diagnosed patients from the outbreak investigation had a 90% survival rate with
treatment compared to a 100% mortality rate with the do-nothing alternative. The disability-
adjusted life years (DALY) or lost years of healthy life associated with the outbreak
investigation was 18 DALYs compared to 171 DALYs associated with the do-nothing
alternative. Thereby, 153 DALYs were averted as a result of the fungal meningitis outbreak
response in New River Valley, compared to the do-nothing alternative. Abbreviations: YLD,
years of life lost due to disability; YLL, years of life lost due to premature mortality.
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TABLE 1
Local Health Department Costs: Costs Expended by the New River Health District to Control the Fungal
Meningitis Outbreak in New River Valley
New River Health District Personnel Total No. of Hours Hourly Wage Cost
Epidemiologists 386 $43.39 $16,748.54
Health District Director 70.5 $95.70 $6,746.85
Planner 32 $48.71 $1,558.72
Environmental Health Manager 12 $42.58 $510.96
Clerical 12 $31.07 $372.84
Administration 8 $20.04 $160.32
Nurse Epidemiologist 16 $35.97 $575.52
Volunteers 143 $26.15 $3,739.45
Total cost $30,413.20
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TABLE 2
Clinical Costs: Cost of Clinical Care in Local Clinical Facilities to Control the Fungal Meningitis Outbreak in
New River Valley
Type of Cost No. of Patients Average Unit Cost Cost
Hospital admission 9 $3,908.11 $35,173.00
Lumbar puncture 12 $285.57 $3,426.84
Cerebrospinal fluid culture 14 $70.00 $980.00
Total cost $39,579.84
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TABLE 3
Potential Cases of Fungal Meningitis in New River Valleya
Lot #
Patients in New River Valley Receiving
Injection Lot Virginia Attack Rate,b % Potential Cases in New River Valley
06292012 only 45 14.44 6.498
06292012 with other lot 7 14.61 1.023
05212012 only 24 1.1 0.264
08102012 only 3 0 0
05212012 + 08102012 0 17 0
05212012 with other lot 12 0 0
Total 91 7.785
a
Fungal meningitis attack rate for different injected lots. Potential attack rate of fungal meningitis in the New River Valley was extracted from lot
numbers and Virginia attack rate.
b
Source: Virginia Department of Health.22
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TABLE 4
Epidemiological Effectiveness of the Fungal Meningitis Outbreak Responsea
Parameter Estimation
Number of potential cases (proxy for incident cases) 7.785
Disability weight 0.615 (95% CI: 0.613, 0.616)
Average duration of treatment of recovered patients (proxy for average duration of
disease)
0.33 years (mean: 4 months; range: 1.5–18 months)
Average duration of treatment of fatal patients ~0 years (range: 1–8 days; 1 outlier case: 44 days)
YLD (outbreak response) 1.427 DALYs
YLD (no response) 0 DALYs
YLD (averted) YLD (no response) − YLD (outbreak response)
 = 0 − 1.427
 = −1.427 DALYs averted ( =1.427 DALYs)
Case fatality rate
 Outbreak response 9.678%
 No outbreak response 100%
Average life expectancy in Virginia 79 years
Average age of patients (proxy for average age of death) 57 years
YLL (outbreak response) 16.58 DALYs
YLL (no response) 171.27 DALYs
YLL (averted) YLL (no response) − YLL (outbreak response)
 = 171.27 − 16.58
 = 154.69 DALYs averted
DALYs (averted) YLD (averted) + YLL (averted)
 = −1.427 + 154.69
 =153.26 DALYs averted
a
Abbreviations: DALY, disability-adjusted life year (1 DALY equals 1 lost year of healthy life; DALY = YLD + YLL); YLD, years lost due to
disability (YLD = number of incident cases × disability Weight × average duration of disease); YLL, years of life lost due to premature death [YLL
= number of incident cases × case fatality rate × (life expectancy - age of death)].
Effectiveness of the fungal meningitis outbreak response in New River Valley was measured by DALYs averted. DALYs is a combined measure of
morbidity (YLD) and mortality (YLL).
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